← Back to headlines
Analyst Confidence in C4 Therapeutics' Cemsidomide Drives Upside Potential
Analysts express strong confidence in C4 Therapeutics' Cemsidomide, projecting a significant 270% upside potential for the company.
20 Feb, 17:00 — 20 Feb, 17:00
ℹOnly 1 source covers this story
